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The aim of our study was to identify predictors for recurrence of epileptic seizures in a large county hospital population. We
identified 956 patients (18–67 years) with ICD 9 code 345 as primary diagnosis, seen at the Central Hospital of Akershus over 7
years (1987–1994). The diagnosis of epilepsy was confirmed for 696 of the patients. These were divided into two groups: (1) no
seizures during the previous year (n = 485) and (2) seizures during the previous year (n = 184). To identify predictors for
recurrence of seizures, we used neurologic deficit, number of AEDs used, CT-scan findings, EEG findings, aetiology, gender, age
below and above 50 years and comorbidity as independent variables in a logistic regression model. In a univariate analysis, the
strongest predictors for recurrence of seizures were: age above 50 years (OR = 5.2; P < 0.0001), known aetiology (OR = 1.4;
P = 0.04) and use of two or more AEDs (OR = 5.7; P < 0.0001). In the multivariate analysis age, more than 50 years
(OR = 1.7; P = 0.0216) and use of two or more AEDs (OR = 5.6; P < 0.0001) were the only predictors for recurrence of
epileptic seizures.
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Attempts have been made to identify predictors for
epilepsy remission and relapse. Young age at seizure
onset, or at diagnosis, have been shown to predict
absence of seizures1–3, however other studies have
not confirmed this4–8. A higher 2-year remission rate
for men compared with women has been shown1, al-
though this difference was not significant. Other stud-
ies demonstrated a slightly higher short term remis-
sion rate for women than men, however this differ-
ence was not significant in the long run3, 5, 9. Aeti-
ology appears to be an important factor in determin-
ing prognosis, but studies have so far been contradic-
tory3–6, 10–12. Patients with complex partial seizures
are reported in some studies to have a higher seizure
recurrence rate than patients with generalized tonic–
clonic seizures13–16, though other studies have shown
little association between seizure and chances of
achieving seizure remission7, 8.
We wanted to identify predictors for recurrence of
epileptic seizures in a large county hospital popula-1059–1311/99/080476 + 04 $12.00/0tion. This patient population was expected to be more
representative of a general population of epilepsy pa-
tients than a population selected from an epilepsy cen-
tre or tertiary care hospital.
MATERIALS AND METHODS
Sample
Through the hospital information system, we iden-
tified 956 patients with epilepsy (ICD 9 code 345)
as a primary diagnosis, either hospitalized or outpa-
tients at the Central Hospital of Akershus over 7 years
(1987–94). We included only patients 18 years and
above in 1987 and 67 years and below in 1994 to re-
duce problems with comorbidity. One of the authors
(M.I.L.) reviewed the medical records of 939 of these
patients, the remaining 17 records were unavailable.
Using standard criteria of a minimum of two unpro-
voked epileptic seizures, the diagnosis of epilepsy was
confirmed in 696 patients. We found reliable data onc© 1999 BEA Trading Ltd
Predictors for recurrence of epileptic seizures 477
Table 1: Sample characteristics.
Number of patients 669
Male (%) 338 (51)
Age; mean (SD) 44 (12)
Seizure free (%) 484 (73)
Aetiology (%)
Idiopathic/cryptogenic 42
Head injury 22
Intracranial tumour 9
Cerebrovascular 7
Cerebral infection 3
Unknown 9
Others 8
Comorbidity (%)
Psychiatric diseases 5
Other neurological diseases 13
Muscular/skeletal diseases 3
Cardiovascular diseases 3
Others 15seizure frequency in 669 patients. The remaining pa-
tients with no seizure information (n = 27) did not
differ in age or gender from the patients with avail-
able seizure information (n = 669). We divided the
669 patients into two groups: (1) no seizures during
the previous year (n = 485) and (2) seizures during
the previous year (n = 184).
There are no neurologists in private practice in this
area, and general practitioners would generally rely
on specialist services at our hospital for diagnosis and
follow-up of all patients with epilepsy. Thus, the pa-
tients included in this study were assumed to be repre-
sentative of the population of epilepsy patients in our
hospital’s catchment area of 280 000 inhabitants.
Data analysis
Possible group differences were tested using a t test
and chi-squared test. Odds ratios for the occurrence of
seizures were estimated with logistic regression analy-
sis. Occurrence of seizures was used as the depen-
dent variable. Independent variables included in the
regression analysis were limited to a maximum of 10,
including those we considered most relevant predic-
tors after review of previous reports1–17. The inde-
pendent variables were: neurologic deficit, number of
AEDs used, CT-scan findings, EEG findings, aetiol-
ogy, gender, age below and above 50 years and neuro-
logic comorbidity. Results of univariate and multivari-
ate analysis are presented as odds ratios with 95%
confidence intervals and p-values. In the multivariate
analysis we used forward stepwise logistic regression,
using a log likelihood ratio test for inclusion of vari-
ables with P < 0.05. All tests were two-sided. We
chose a 5% significance level. The SPSS for Windows
statistical software version 8.0 (SPSS Inc., Chicago,
IL) was used for all analyses.
RESULTS
Of the 669 patients 50% were male. Mean age was
44 years, range 26–67 years. Further characteristics
for the sample is shown in Table 1. In the univari-
ate logistic regression analysis, the strongest predic-
tors for recurrence of epileptic seizures were: age more
than 50 years, known aetiology and two or more AEDs
(Table 2). In the multivariate analysis, age more than
50 years and two or more AEDs were the only sig-
nificant predictors for recurrence of epileptic seizures
(Table 3).DISCUSSION
Our study showed an association between age above
50 years and recurrence of epileptic seizures. We also
found the number of AEDs used to be a significant
predictor of recurrence of epileptic seizures. In earlier
studies, seizure recurrence has been related to age at
seizure onset or at diagnosis; Hauser et al.1 found an
overall remission rate of approximately 50% for pa-
tients aged 1–39 years at diagnosis and 29% for pa-
tients aged 40–59 years. Patients above 59 years at
diagnosis had a remission rate of 17%. Our findings
of a higher rate of recurrence of seizures at advanced
age is in accord with this. However, Beghi et al.4 found
no difference in recurrence of epileptic seizures in re-
lationship with age at onset of seizures. These differ-
ent results might be explained by differences in study
designs. The association between age above 50 years
and recurrence of epileptic seizures might be caused
by better follow-up of young patients, that freedom
from seizures is targeted more aggressively in young
patients than in older patients, or that compliance is
poorer in older patients.
The number of AEDs used has been found to be an
important predictor for recurrence of epileptic seizures
after drug withdrawal17, which was also confirmed in
our study. Known aetiology has also been shown to be
a predictor of seizure recurrence in earlier studies10–12,
although some studies could not confirm this3–6. The
diverging results in these studies may be explained by
variations in study methods and design.
Our study was retrospective, based on a cross-
sectional sample, with the weaknesses and limitations
of such studies. Seizure type was not included in the
regression analysis because of the uncertainty about
seizure classification in our retrospective data. The
majority of Norwegian epilepsy patients visit hospital
outpatient clinics regularly, whether they have seizures
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Table 2: Odds ratios for the occurrence of seizures in 669 patients with confirmed epilepsy (univariate logistic regression
analysis).
Variable OR 95%CI P n
Neurological deficit No vs. yes 0.8 0.5 1.2 0.23 644
Antiepileptic drug One vs. none 1.2 0.8 1.9 0.39 669
At least two vs. none 4.6 2.6 8.2 <0.0001 669
Cerebral CT Normal vs. pathological 1 0.7 1.4 0.88 559
EEG changes Focal vs. not focal 0.9 0.6 1.3 0.43 625
Generalized vs. not generalized 1.7 0.6 5 0.35 624
Aetiology Known vs. unknown 1.5 1 2 0.03 606
Head trauma vs. not 1 0.7 1.5 0.99 606
Gender Female vs. male 1.2 0.9 1.8 0.16 669
Age ≥50 years vs. <50 years 1.6 1.1 2.2 0.02 669
Neurological comorbidity No vs. yes 1.2 0.8 1.8 0.43 641
OR = Odds ratio; 95% CI = Confidence interval.
Table 3: Odds ratios for occurrence of seizures in patients with confirmed epilepsy (multivariate logistic regression analysis
(n = 486)).
Variable OR 95%CL P
Age ≥50 years vs. <50 years 1,7 1,1 2,6 0.0216
Antiepileptic drug At least two vs. none 5.6 2.7 11,9 <0.0001
OR = Odds ratio; 95% CI = Confidence interval.
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